A randomized, controlled trial of an aerosolized vaccine against measles.
about
Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza VaccinesAssessing the Potential Cost-Effectiveness of Microneedle Patches in Childhood Measles Vaccination Programs: The Case for Further Research and Development.Harnessing Local Immunity for an Effective Universal Swine Influenza VaccinePerspective on Global Measles Epidemiology and Control and the Role of Novel Vaccination StrategiesAerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus.Distinct immune responses and virus shedding in pigs following aerosol, intra-nasal and contact infection with pandemic swine influenza A virus, A(H1N1)09Variability in Humoral Immunity to Measles Vaccine: New Developments.Multifunctional particle-constituted microneedle arrays as cutaneous or mucosal vaccine adjuvant-delivery systemsMeasles vaccine: Past, present, and future.Microneedle arrays delivery of the conventional vaccines based on nonvirulent viruses.Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation.Anti-Infectious Human Vaccination in Historical Perspective.The Reemergence of Measles.Creation of a protective pulmonary bioshield against inhaled organophosphates using an aerosolized bioscavenger.Measles Vaccine.A review of measles control in Kenya, with focus on recent innovations.Needle-free delivery of measles virus vaccine to the lower respiratory tract of non-human primates elicits optimal immunity and protection.Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection.A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques.Therapeutic Administration of Broadly Neutralizing FI6 Antibody Reveals Lack of Interaction Between Human IgG1 and Pig Fc Receptors.Measles
P2860
Q26744622-E3B402BF-4BC3-4FE2-BAAC-1DCCCF58191EQ30151736-D799542F-E205-4146-B53E-AAC6897EC899Q30234558-B7EBA0C8-3E08-4B6B-B793-8F240238A7A7Q30238913-C96A1C80-D34E-41CB-A736-2EB1D266F2D6Q30388110-96241BB6-D0AC-4A62-9D75-17D734422C2CQ30394336-F0848686-A409-4FBD-86DC-CB75CA1BF662Q36373260-8369A493-BA77-4052-B716-27E338E2EA8FQ37197084-E6BE2A5B-C796-4885-B24B-5EF84B3B002AQ38560170-45006EA5-EC90-4964-BA61-FCDF8A89A9A5Q38770048-7077AFC4-97C2-4470-AA81-EAB96BB7312AQ40106084-6A156165-D08C-4B99-92D1-92FB197115B7Q40129444-A62F409A-737B-426C-B2FD-AA5FA5BE9036Q40136026-D696C1AC-E55B-431A-A71D-764B709815BAQ42094010-EB0DE249-96B0-4981-A566-660AA81D4272Q46300761-D5D48EFD-E423-444E-BF99-3113542DC3ABQ47102442-CC1D1003-BE9E-4839-BB11-974A8D7D9654Q47141816-C23B7515-4197-4E11-A4D8-0C707433886FQ47649982-EFFEE1D2-14A9-4D4F-B98E-A977C427BE28Q52559076-D0A069DE-5D53-4417-BA2B-36AEF654F9EDQ54217589-F84EDF8C-8A5E-4DC2-B6B1-B5245CA13DDBQ55970012-9956B5A3-BCE7-4829-B8B4-9D642CC1FC35
P2860
A randomized, controlled trial of an aerosolized vaccine against measles.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
A randomized, controlled trial of an aerosolized vaccine against measles.
@en
type
label
A randomized, controlled trial of an aerosolized vaccine against measles.
@en
prefLabel
A randomized, controlled trial of an aerosolized vaccine against measles.
@en
P2093
P50
P356
P1476
A randomized, controlled trial of an aerosolized vaccine against measles.
@en
P2093
A Ximena Riveros-Balta
Arunachalam Rajagopal
Ashish Bavdekar
David Brown
James B Fink
Kavitha Ramanathan
Kevin E Brown
Lakshmanan Jeyaseelan
Michel Greco
Naseem Shaikh
P304
P356
10.1056/NEJMOA1407417
P407
P577
2015-04-01T00:00:00Z